Clinical Trial Update: Does Fampridine SR Improve Cognitive Fatigue in Multiple Sclerosis Patients? [Phase 2, Phase 3]

View source ↗

Summary

This update reports on Phase 2 and Phase 3 trials evaluating whether sustained-release fampridine (dalfampridine) improves cognitive fatigue in people with mult…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• Fampridine-SR (fampridine)

Snippet

Sponsor: London Health Sciences Centre | Conditions: Cognitive Fatigue | Phase 2, Phase 3 | Status: COMPLETED